150 related articles for article (PubMed ID: 36002314)
1. Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT).
Laroche ML; Gautier S; Polard E; Rabier MB; Chouchana L; Lebrun-Vignes B; Faillie JL; Petitpain N; Lagarce L; Jonville-Bera AP;
Br J Clin Pharmacol; 2023 Jan; 89(1):390-400. PubMed ID: 36002314
[TBL] [Abstract][Full Text] [Related]
2. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
Bénard-Laribière A; Miremont-Salamé G; Pérault-Pochat MC; Noize P; Haramburu F;
Fundam Clin Pharmacol; 2015 Feb; 29(1):106-11. PubMed ID: 24990220
[TBL] [Abstract][Full Text] [Related]
3. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: a study in a French emergency department.
Olivier P; Boulbés O; Tubery M; Lauque D; Montastruc JL; Lapeyre-Mestre M
Drug Saf; 2002; 25(14):1035-44. PubMed ID: 12408734
[TBL] [Abstract][Full Text] [Related]
4. Postdischarge adverse drug reactions in primary care originating from hospital care in France: a nationwide prospective study.
Letrilliart L; Hanslik T; Biour M; Fagot JP; Guiguet M; Flahault A
Drug Saf; 2001; 24(10):781-92. PubMed ID: 11676305
[TBL] [Abstract][Full Text] [Related]
5. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study.
Angamo MT; Curtain CM; Chalmers L; Yilma D; Bereznicki L
PLoS One; 2017; 12(10):e0186631. PubMed ID: 29036230
[TBL] [Abstract][Full Text] [Related]
6. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study.
Mehta U; Durrheim DN; Blockman M; Kredo T; Gounden R; Barnes KI
Br J Clin Pharmacol; 2008 Mar; 65(3):396-406. PubMed ID: 18070223
[TBL] [Abstract][Full Text] [Related]
7. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
Geer MI; Koul PA; Tanki SA; Shah MY
J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
[TBL] [Abstract][Full Text] [Related]
8. Measuring the preventability of adverse drug reactions in France: A 2015 overview.
Olivier-Abbal P
Therapie; 2016 Apr; 71(2):195-202. PubMed ID: 27080838
[TBL] [Abstract][Full Text] [Related]
9. [Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale].
Olivier P; Caron J; Haramburu F; Imbs JL; Jonville-Béra AP; Lagier G; Sgro C; Vial T; Montastruc JL; Lapeyr-Mestre M
Therapie; 2005; 60(1):39-45. PubMed ID: 15929472
[TBL] [Abstract][Full Text] [Related]
10. [Preventability of adverse effects in a medical emergency service].
Olivier P; Boulbès O; Tubery M; Carles P; Montastruc JL; Lapeyre-Mestre M
Therapie; 2001; 56(3):275-8. PubMed ID: 11482315
[TBL] [Abstract][Full Text] [Related]
11. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.
van der Hooft CS; Sturkenboom MC; van Grootheest K; Kingma HJ; Stricker BH
Drug Saf; 2006; 29(2):161-8. PubMed ID: 16454543
[TBL] [Abstract][Full Text] [Related]
12. Preventable ADRs leading to hospitalization - results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients.
Schmiedl S; Rottenkolber M; Szymanski J; Drewelow B; Siegmund W; Hippius M; Farker K; Guenther IR; Hasford J; Thuermann PA;
Expert Opin Drug Saf; 2018 Feb; 17(2):125-137. PubMed ID: 29258401
[TBL] [Abstract][Full Text] [Related]
13. Frequency and cost of serious adverse drug reactions in a department of general medicine.
Moore N; Lecointre D; Noblet C; Mabille M
Br J Clin Pharmacol; 1998 Mar; 45(3):301-8. PubMed ID: 9517375
[TBL] [Abstract][Full Text] [Related]
14. A prospective analysis of the preventability of adverse drug reactions reported in Sweden.
Lövborg H; Eriksson LR; Jönsson AK; Bradley T; Hägg S
Eur J Clin Pharmacol; 2012 Aug; 68(8):1183-9. PubMed ID: 22349466
[TBL] [Abstract][Full Text] [Related]
15. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Adverse Drug Reaction in the Medical Wards of a Teaching Hospital: A Prospective Observational Cohort Study.
Peter JV; Varghese GH; Alexander H; Tom NR; Swethalekshmi V; Truman C; Kumar TR; Sivakumar T
Curr Drug Saf; 2016; 11(2):164-71. PubMed ID: 26916785
[TBL] [Abstract][Full Text] [Related]
17. Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals.
Parameswaran Nair N; Chalmers L; Bereznicki BJ; Curtain C; Peterson GM; Connolly M; Bereznicki LR
Drug Saf; 2017 Jul; 40(7):597-606. PubMed ID: 28382494
[TBL] [Abstract][Full Text] [Related]
18. Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports.
Egron A; Olivier-Abbal P; Gouraud A; Babai S; Combret S; Montastruc JL; Bondon-Guitton E
Target Oncol; 2015 Jun; 10(2):229-34. PubMed ID: 25056801
[TBL] [Abstract][Full Text] [Related]
19. Cohort study on adverse drug reactions in adults admitted to the medical wards of a tertiary hospital in Nigeria: Prevalence, incidence, risk factors and fatality.
Adedapo ADA; Adedeji WA; Adedapo IA; Adedapo KS
Br J Clin Pharmacol; 2021 Apr; 87(4):1878-1889. PubMed ID: 32991765
[TBL] [Abstract][Full Text] [Related]
20. Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre.
Jonville-Béra AP; Saissi H; Bensouda-Grimaldi L; Beau-Salinas F; Cissoko H; Giraudeau B; Autret-Leca E
Drug Saf; 2009; 32(5):429-40. PubMed ID: 19419237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
